BL
ARNA

Bolton LP’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bolton LP’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,590
Closed -$738K – 145
2014
Q2 		$738K Sell
12,590
-25,970
-67% -$1.64M 0.11% 84
2014
Q1 		$2.43M Buy
38,560
+38,204
+10,731% +$2.53M 0.56% 45
2013
Q4 		$1.1M Buy
+356
New +$18.6K 0.2% 63

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bolton LP's ARNA Position: Q3 2014 in Review

Bolton LP sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2014, closing a stake of 12,620 shares — an estimated $740K sold.

Bolton LP first reported a position in ARNA in Q3 2013 and held it in 4 quarters. The position peaked at $2.36M in Q1 2014. 121 funds tracked by Wall St. Rank hold ARNA as of Q3 2014.

  • Bolton LP reported no remaining Arena Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Bolton LP sold 12,620 Arena Pharmaceuticals Inc shares in Q3 2014, an estimated $740K.
  • Bolton LP first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 4 quarters.
  • Bolton LP's Arena Pharmaceuticals Inc position peaked at $2.36M in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2014.

Based on Bolton LP's 13F filing for Q3 2014, filed 14 Nov 2014.